95 related articles for article (PubMed ID: 4005126)
1. Influence of site of drug delivery on the systemic availability of metoprolol: comparison of intragastric infusion and 14/190 Oros administration.
Warrington SJ; Barclay SP; John VA; Shotton PA; Wardle HM; Good W
Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):219S-224S. PubMed ID: 4005126
[TBL] [Abstract][Full Text] [Related]
2. Osmotically controlled-delivery of metoprolol in man: in vivo performance of Oros systems with different durations of drug release.
Godbillon J; Gerardin A; Richard J; Leroy D; Moppert J
Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):213S-218S. PubMed ID: 4005125
[TBL] [Abstract][Full Text] [Related]
3. Influence of food on the absorption of metoprolol administered as an Oros drug delivery system to man.
Lecaillon JB; Massias P; Schoeller JP; Abadie F
Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):245S-249S. PubMed ID: 4005130
[TBL] [Abstract][Full Text] [Related]
4. Comparison of single-dose pharmacokinetic and pharmacodynamic properties of two metoprolol Oros systems with different initial zero-order release rates.
Warrington SJ; Barclay SP; John VA; Shotton PA; Good W
Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):225S-230S. PubMed ID: 4005127
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of oxprenolol and metoprolol Oros systems in the dog: comparison of in vivo and in vitro drug release, and of drug absorption from duodenal and colonic infusion sites.
Fara JW; Myrback RE; Swanson DR
Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):91S-95S. PubMed ID: 4005134
[TBL] [Abstract][Full Text] [Related]
6. A multiple dose pharmacokinetic and pharmacodynamic evaluation of conventional and 19/285 Oros formulations of metoprolol in healthy volunteers.
Grainger SL; John VA; Shotton PA; Smith SE
Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):239S-244S. PubMed ID: 4005129
[TBL] [Abstract][Full Text] [Related]
7. Stable isotope methodology for studying the performance of metoprolol Oros tablets in comparison to conventional and slow release formulations.
Richard J; Cardot JM; Godbillon J
Eur J Drug Metab Pharmacokinet; 1994; 19(4):375-80. PubMed ID: 7737240
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic investigation of the absorption of oxprenolol from Oros delivery systems in healthy volunteers: comparison of in vivo and in vitro drug release.
Bradbrook ID; John VA; Morrison PJ; Rogers HJ; Spector RG
Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):163S-169S. PubMed ID: 4005118
[TBL] [Abstract][Full Text] [Related]
9. Controlled release metoprolol formulations. A review of their pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and ischaemic heart disease.
Plosker GL; Clissold SP
Drugs; 1992 Mar; 43(3):382-414. PubMed ID: 1374320
[TBL] [Abstract][Full Text] [Related]
10. Oros controlled-release formulations of metoprolol: an approach to the development of a system for once daily administration.
Good W; Leeson LJ; Zak SL; Wagner WE; Meeker JB; Arnold JD
Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):231S-238S. PubMed ID: 4005128
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal transit of Oros drug delivery systems in healthy volunteers: a short report.
John VA; Shotton PA; Moppert J; Theobald W
Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):203S-206S. PubMed ID: 4005123
[TBL] [Abstract][Full Text] [Related]
12. Steady-state bioavailability and day-to-day variability of a multiple-unit (CR/ZOK) and a single-unit (OROS) delivery system of metoprolol after once-daily dosing.
Sandberg A; Abrahamsson B; Svenheden A; Olofsson B; Bergstrand R
Pharm Res; 1993 Jan; 10(1):28-34. PubMed ID: 8430057
[TBL] [Abstract][Full Text] [Related]
13. Reproducibility of oxprenolol plasma concentrations in young female volunteers following oral administration of an oxprenolol Oros dosage form.
Jack DB; Kendall MJ; Laugher SJ; Smith SR
Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):185S-190S. PubMed ID: 4005121
[TBL] [Abstract][Full Text] [Related]
14. Relationship between systemic drug absorption and gastrointestinal transit after the simultaneous oral administration of carbamazepine as a controlled-release system and as a suspension of 15N-labelled drug to healthy volunteers.
Wilding IR; Davis SS; Hardy JG; Robertson CS; John VA; Powell ML; Leal M; Lloyd P; Walker SM
Br J Clin Pharmacol; 1991 Nov; 32(5):573-9. PubMed ID: 1954073
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the pharmacodynamic and pharmacokinetic profiles of single and multiple doses of a commercial slow-release metoprolol formulation with a new Oros delivery system.
Kendall MJ; Jack DB; Woods KL; Laugher SJ; Quarterman CP; John VA
Br J Clin Pharmacol; 1982 Mar; 13(3):393-8. PubMed ID: 7059440
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic and pharmacodynamic comparison of an osmotic release oral metoprolol tablet and the metoprolol conventional tablet.
Feliciano NR; Bouvet AA; Redalieu E; Castellana J; Luders RC; Schwartz DJ; Shum L; Zak S; Arnold JD; Leese PT
Am Heart J; 1990 Aug; 120(2):483-9. PubMed ID: 2382633
[TBL] [Abstract][Full Text] [Related]
17. Influence of food on the bioavailability of metoprolol from an OROS system; a study in healthy volunteers.
van den Berg G; van Steveninck F; Gubbens-Stibbe JM; Schoemaker HC; de Boer AG; Cohen AF
Eur J Clin Pharmacol; 1990; 39(3):315-6. PubMed ID: 2257873
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo deconvolution assessment of drug release kinetics from oxprenolol Oros preparations.
Langenbucher F; Mysicka J
Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):151S-162S. PubMed ID: 4005117
[TBL] [Abstract][Full Text] [Related]
19. The effect of impaired renal function on the pharmacokinetics of metoprolol after single administration of a 14/190 metoprolol OROS system.
Lloyd P; John VA; Signy M; Smith SE
Am Heart J; 1990 Aug; 120(2):478-82. PubMed ID: 2382632
[TBL] [Abstract][Full Text] [Related]
20. Influence of food intake on plasma oxprenolol concentrations following oral administration of conventional and Oros preparations.
John VA; Smith SE
Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):191S-195S. PubMed ID: 4005122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
